Contracts
Apr. 1, 2011
$3.4 Million Verdict a Win for Abbott
A federal jury found Abbott Laboratories must pay $3.4 million to competitor GlaxoSmithKline after a month-long antitrust and breach of contract trial in Oakland. GSK had been seeking $571 million in damages.
Daily Journal Staff Writer
For raising the price of an HIV drug by 400 percent, Abbott Laboratories must pay competitor GlaxoSmithKline $3.49 million, according to a verdict returned by an Oakland federal jury Wednesday after a month-long antitrust and breach of contract trial.
The verdict is a major victory for Abbott, as GlaxoSmithKline sought more than $571 million in damages. The jury did not find in GSK's favor on any...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In